Saltar al contenido
Merck

Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome.

Cell reports (2015-04-30)
Christina Gross, Chia-Wei Chang, Seth M Kelly, Aditi Bhattacharya, Sean M J McBride, Scott W Danielson, Michael Q Jiang, Chi Bun Chan, Keqiang Ye, Jay R Gibson, Eric Klann, Thomas A Jongens, Kenneth H Moberg, Kimberly M Huber, Gary J Bassell
RESUMEN

The PI3K enhancer PIKE links PI3K catalytic subunits to group 1 metabotropic glutamate receptors (mGlu1/5) and activates PI3K signaling. The roles of PIKE in synaptic plasticity and the etiology of mental disorders are unknown. Here, we show that increased PIKE expression is a key mediator of impaired mGlu1/5-dependent neuronal plasticity in mouse and fly models of the inherited intellectual disability fragile X syndrome (FXS). Normalizing elevated PIKE protein levels in FXS mice reversed deficits in molecular and cellular plasticity and improved behavior. Notably, PIKE reduction rescued PI3K-dependent and -independent neuronal defects in FXS. We further show that PI3K signaling is increased in a fly model of FXS and that genetic reduction of the Drosophila ortholog of PIKE, CenG1A rescued excessive PI3K signaling, mushroom body defects, and impaired short-term memory in these flies. Our results demonstrate a crucial role of increased PIKE expression in exaggerated mGlu1/5 signaling causing neuronal defects in FXS.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anticuerpo anti-receptor metabotrópico 5 del glutamato, dolor, Chemicon®, from rabbit
Sigma-Aldrich
Anti-FMR1 (C-terminal) antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-PI3 Kinase Antibody, p110β, from rabbit, purified by affinity chromatography